emphasised the clinical value of preoperative immunonutrition for reducing complications and length of stay (LOS) and improving postoperative nutritional indices (e.g., the NRI and serum albumin concentration) in patients with advanced pancreatic disease. The gene discussed is ALB; the disease is pancreas disorder.